Falling US flu vaccine rates hurt Australia's CSL profit growth

Financial Performance- 2 min read
Falling US flu vaccine rates hurt Australia's CSL profit growth
CSL, the world's second-largest maker of flu vaccines, also warned that the trend of lower immunisation posed a public health risk for the U.S
Read more...